One Compartment Model

Renal Excretion and Liver Metabolism Models

Renal clearance can be determined from filtration, secretion and reabsorption parameters according to equation 16.2.1. Each of these rates can be explored further in terms of fraction unbound (f

**Equation 16.2.1 Renal clearance expanded (Bauer, p 14)**

**Equation 16.2.2 Hepatic Clearance according to the Well Stirred Model**

Parameter |
Value |
Comment |

Dose | 500 mg ± | Linear system in this example |

Absorption rate half-life, t_{1/2}abs |
Range 0.1 - 24 hr | |

Fraction absorbed F |
Range 0 - 1.0 | |

Volume of Distribution V |
Range 7 - 200+ L | |

Hepatic Blood Flow Q _{H} |
90 L/hr Range 60-120 L/hr |
70 Kg adult, Shargel and Yu, 3rd, 1993 |

Renal Blood Flow Q _{H} |
72 L/hr |
70 Kg adult, Shargel and Yu, 3rd, 1993 |

Glomerular Filtration Rate, GFR | 0 - 7.8+ L/hr | Shargel and Yu, 3rd, 1993 |

Hepatic Intrinsic Clearance CL _{int, ub} |
0 - 1620+ L/hr | Shargel and Yu, 3rd, 1993 |

Renal Secretion Clearance CL _{sec, ub} |
0 - 39.0+ L/hr | Shargel and Yu, 3rd, 1993 |

Fraction Reabsorbed Renal | 0 - 1.0 |

Equations used in this simple pharmacokinetic model.

**Equation 16.2.3 Elimination Rate Constant as a function of CL _{H}, CL_{R} and V**

**Equation 16.2.4 Absorption rate constant**

**Equation 16.2.5 Concencentration versus Time after a single IV Bolus Dose**

Explore flow limited drug behavior by setting CL_{int} somewhat larger (> 200 L/hr) than the hepatic blood flow rate. Change Q_{H}, fu and CL_{int} to see which parameters have the greatest influence of half-life. Capacity limited drug behavior can be explored by setting CL_{int} to a lower value (< 40 L/hr). Explore the effect of V on drug half-life.

Explore the model by changing the parameter(s). Add additional lines with different parameter values using the Plot Line button.

- Bauer, L.A. 2008
**Applied Pharmacokinetics**, Second Edition, McGraw-Hill, New York, NY - Burton, M.E., Shaw, L.M., Schentag, J.J., and Evans, W.E. (editors) 2006.
**Applied Pharmacokinetics & Pharmacodynamics, Principles of Therapeutic Drug Monitoring**, Lippincott Williams & Wilkins, p133 - Kwon, Y. 2001
**Handbook of Essential Pharmacokinetics, Pharmacodynamics, and Drug Metabolism for Industrial Scientists**, Kluwer Academic/Plenum Publishers, pp 90-95 - Shargel, L., Wu-Pong, S. and Yu, A.B.C. 2005
**Applied Biopharmaceutics and Pharmacokinetics**, 5th ed., McGraw-Hill, pp 342-343

This page was last modified: Saturday, 4th Nov 2017 at 9:22 pm

Privacy Statement - 25 May 2018

Material on this website should be used for Educational or Self-Study Purposes Only

iBook and pdf versions of this material and other PK material is available

Copyright © 2001-2021 David W. A. Bourne (david@boomer.org)